We are live on ! Find out more
GP

Girard Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 17.26%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+17.26%
3 Year Est. Return
+25.75%
5 Year Est. Return
+90.99%
10 Year Est. Return
+213.34%
AUM
$484M
AUM Growth
+$22.4M
Cap. Flow
+$7.14M
Cap. Flow %
1.47%
Top 10 Hldgs %
21.94%
Holding
277
New
12
Increased
123
Reduced
102
Closed
19

Sector Composition

Rank Sector Weight
1 Healthcare 14.57%
2 Financials 12.06%
3 Technology 10.94%
4 Industrials 8.97%
5 Consumer Discretionary 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DD
276
DELISTED
Du Pont De Nemours E I
DD
-6,814
Closed -$550K
RAI
277
DELISTED
Reynolds American Inc
RAI
-19,687
Closed -$1.28M

Similar funds

Girard Partners's Q3 2017 Portfolio in Review

As of Q3 2017, Girard Partners held 277 positions worth $484M, up 4.9% from $462M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Girard Partners's Q3 2017 filing shows 12 new, 123 increased, 102 reduced and 19 closed positions. Its largest new stake was British American Tobacco: 8,381 shares worth $523K. The largest sale was DuPont de Nemours, an estimated $1.57M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

  • Girard Partners's largest Q3 2017 buy was British American Tobacco: 8,381 shares worth $523K.
  • Girard Partners added most to iShares Core US Aggregate Bond ETF in Q3 2017, an estimated $920K increase.
  • Girard Partners's biggest Q3 2017 reduction was Procter & Gamble, cutting an estimated $340K.
  • Girard Partners fully exited DuPont de Nemours in Q3 2017, selling an estimated $1.57M.
  • Girard Partners's ten largest holdings make up 22% of its $484M portfolio in Q3 2017.
  • Girard Partners opened 12 new positions and closed 19 in Q3 2017.
  • Girard Partners's portfolio value rose 4.9% quarter-over-quarter to $484M.

Based on Girard Partners's 13F filing for Q3 2017, filed 8 Nov 2017.